Economy
Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars
Headline as filed by MarketWatch.
Compare coverage — 1 report
| Publisher | Headline | Summary | Published | Detected | Delay | Source | Status |
|---|---|---|---|---|---|---|---|
| MarketWatch | Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars |
The Danish drug giant behind Ozempic is competing with Eli Lilly in the market for weight-loss drugs. |
0m | marketwatch.com | First |
Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.
Reader comments
Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.
Nobody has commented on this story yet.